SMARCA4-deficient sarcoma of thorax
MONDO:0018761Also known as: SMARCA4-deficient thoracic sarcoma
2832 clinical trials for this condition and its sub-types, 8 tagged with SMARCA4-deficient sarcoma of thorax itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Promising combo targets rare lung cancer in new trial
Disease control Not yet recruitingThis study tests a combination of anlotinib pills and standard chemotherapy for people with a rare, advanced lung cancer that lacks the SMARCA4 gene. About 28 adults will receive the treatment in 21-day cycles to see how long it keeps the cancer from growing and what side effects…
Phase 2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo targets rare lung cancer in early trial
Disease control Not yet recruitingThis study tests a new drug combination (iparomlimab and tuvonralimab) plus chemotherapy as a first treatment for people with a rare, advanced lung cancer that lacks the SMARCA4 gene. The goal is to see if this approach can shrink tumors or delay cancer growth. About 28 adults wi…
Phase 2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC